{"entity":{"type":"insider","cik":"0001776087","url":"/insider/0001776087","json_url":"/insider/0001776087.json","name":"Pfizer Ventures (US) LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2019-05-14","last":"2023-03-23","span_basis":"filed_date"},"name_variants":[{"name":"Pfizer Ventures (US) LLC","source":"filing","n_filings":6,"first_seen":"2019-05-14","last_seen":"2023-03-23"}],"transactions":[{"id":9197208,"accession":"0000078003-23-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000078003-23-000052","line_url":"/filing/0000078003-23-000052#line-1","is_derivative":false,"issuer_cik":"0001782223","issuer_name":"Pyxis Oncology, Inc.","issuer_ticker":"PYXS","issuer_name_source":null,"issuer_url":"/issuer/0001782223","owner_cik":null,"owner_name":"PFIZER INC; Pfizer Ventures (US) LLC","owner_display_name":"PFIZER INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1811594.0,"shares_display":"1,811,594","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":4999999.44,"total_display":"4,999,999.44","total_whole":"4,999,999","shares_owned_after":5952263.0,"shares_owned_after_display":"5,952,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-23","scope":"insider"},{"id":8272613,"accession":"0000078003-23-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000078003-23-000050","line_url":"/filing/0000078003-23-000050#line-1","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"Pyxis Oncology, Inc.","issuer_ticker":"PYXS","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":null,"owner_name":"Pfizer Ventures (US) LLC; PFIZER INC","owner_display_name":"Pfizer Ventures (US) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1811594.0,"shares_display":"1,811,594","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":4999999.44,"total_display":"4,999,999.44","total_whole":"4,999,999","shares_owned_after":5952263.0,"shares_owned_after_display":"5,952,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":2627402,"accession":"0000078003-20-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000078003-20-000038","line_url":"/filing/0000078003-20-000038#line-1","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":null,"owner_name":"Pfizer Ventures (US) LLC; PFIZER INC; Pfizer Strategic Investment Holdings LLC","owner_display_name":"Pfizer Ventures (US) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370000.0,"shares_display":"370,000","price_per_share":40.18,"price_display":"40.18","price_state":"stated","total_value":14866600.0,"total_display":"14,866,600.00","total_whole":"14,866,600","shares_owned_after":2879973.0,"shares_owned_after_display":"2,879,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-04","scope":"insider"},{"id":2627397,"accession":"0000078003-20-000023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000078003-20-000023","line_url":"/filing/0000078003-20-000023#line-4","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":null,"owner_name":"PFIZER INC; Pfizer Ventures (US) LLC","owner_display_name":"PFIZER INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1481719.0,"shares_owned_after_display":"1,481,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":8606639,"accession":"0000078003-19-000071","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000078003-19-000071","line_url":"/filing/0000078003-19-000071#line-4","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":null,"owner_name":"Pfizer Ventures (US) LLC; PFIZER INC","owner_display_name":"Pfizer Ventures (US) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":4593847.0,"shares_owned_after_display":"4,593,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-17","filed_date":"2019-09-19","scope":"insider"},{"id":8579782,"accession":"0000078003-19-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000078003-19-000027","line_url":"/filing/0000078003-19-000027#line-4","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":null,"owner_name":"PFIZER INC; Pfizer Strategic Investment Holdings LLC; Pfizer Ventures (US) LLC","owner_display_name":"PFIZER INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":850000.0,"total_display":"850,000.00","total_whole":"850,000","shares_owned_after":3249973.0,"shares_owned_after_display":"3,249,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001782223","name":"Pyxis Oncology, Inc.","url":"/issuer/0001782223","role":"Ten percent owner","n_filings":2,"first_seen":"2023-03-21","last_seen":"2023-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001662774","name":"Cortexyme, Inc.","url":"/issuer/0001662774","role":"Ten percent owner","n_filings":2,"first_seen":"2019-05-14","last_seen":"2020-06-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Ten percent owner","n_filings":1,"first_seen":"2020-03-16","last_seen":"2020-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Ten percent owner","n_filings":1,"first_seen":"2019-09-19","last_seen":"2019-09-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776087","retrieved_at":"2026-08-26T04:04:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}